This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Church & Dwight (CHD) Shares Up 21.9% YTD: What's Driving It?
by Zacks Equity Research
Church & Dwight (CHD) gains from its strength across end markets, acquired assets, its solid online channel and shareholder-friendly policies.
Zacks Investment Ideas feature highlights: Lamb Weston, Coca-Cola and Clorox
by Zacks Equity Research
Lamb Weston, Coca-Cola and Clorox are part of the Zacks Investment Ideas article.
3 Stocks Tailored Toward a Defensive Approach
by Derek Lewis
These companies' products have an advantageous ability to generate consistent demand in the face of many economic situations. And recently, analysts have become optimistic surrounding their outlooks.
Helen of Troy (HELE) Readies for Q1 Earnings: Things to Note
by Zacks Equity Research
Helen of Troy's (HELE) first-quarter results are likely to reflect the impacts of a tough operating landscape, including volatile consumer spending, while a focus on Project Pegasus bodes well.
Why You Must Consider Colgate (CL) Stock Before Q2 Earnings
by Zacks Equity Research
Colgate (CL) is well-poised on its innovation efforts, pricing actions, digital capabilities and progress on revenue growth management initiatives.
Best Growth Stocks to Buy for June 30th
by Zacks Equity Research
AMWD, CLX and TOL made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 30, 2023.
Clorox (CLX) Surpasses the Industry in a Year: Here's How
by Zacks Equity Research
Clorox (CLX) is poised to benefit from pricing gains and cost savings efforts, along with a solid innovation pipeline, digital transformation and its IGNITE strategy.
Best Growth Stocks to Buy for June 27th
by Zacks Equity Research
BEKE, CLX and PHM made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 27, 2023.
Top 5 Dividend-Paying Low-Beta Stocks Amid Recent Volatility
by Nalak Das
We have narrowed our search to five dividend-paying low-beta stocks. These are: CLX, GGG, MLM, VMC, KNSL.
Bull Of The Day: Clorox (CLX)
by Brian Bolan
This is more of an earning growth story than a revenue growth story.
What Makes Clorox (CLX) a New Strong Buy Stock
by Zacks Equity Research
Clorox (CLX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Best Income Stocks to Buy for June 23rd
by Zacks Equity Research
CLX, GEF and KMT made it to the Zacks Rank #1 (Strong Buy) income stocks list on June 23, 2023.
5 High-Yielding Stocks to Buy for a Stable Portfolio
by Nalak Das
We have narrowed our search to five high dividend paying stocks with strong potential for the rest of 2023. These are: CAG, CLX, BAP, KHC and NEM.
Here's Why Procter & Gamble (PG) is an Attractive Pick Now
by Zacks Equity Research
Procter & Gamble (PG) is a lucrative pick on its ongoing business momentum, strength across businesses, pricing actions and productivity plans.
Are Consumer Staples Stocks Lagging Clorox (CLX) This Year?
by Zacks Equity Research
Here is how Clorox (CLX) and Coty (COTY) have performed compared to their sector so far this year.
Why Investors Need to Take Advantage of These 2 Consumer Staples Stocks Now
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Down -7.81% in 4 Weeks, Here's Why Clorox (CLX) Looks Ripe for a Turnaround
by Zacks Equity Research
The heavy selling pressure might have exhausted for Clorox (CLX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Colgate (CL) Looks Solid on Pricing Action & Expansion Strategy
by Zacks Equity Research
Pricing actions, revenue management initiatives, innovation, brand strength and digital growth position Colgate (CL) for growth amid higher costs and currency headwinds.
Invest in 5 Top Stocks Set to Exceed Earnings Estimates
by Sanghamitra Saha
These top-ranked stocks are likely to beat on the bottom line in their next releases. Tap Clorox (CLX), Wingstop (WING), Tri Pointe Homes (TPH), Clarivate (CLVT) and SPX Technologies Inc. (SPXC) for gains.
Here's Why You Should Consider Investing in Clorox (CLX)
by Zacks Equity Research
Clorox (CLX) is poised to gain from strength across its businesses, digital investments, pricing actions and cost reduction actions.
Best Growth Stocks to Buy for June 12th
by Zacks Equity Research
ENS, GPK and CLX made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 12, 2023.
Best Growth Stocks to Buy for June 8th
by Zacks Equity Research
ENS, CLX and GPK made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 8th, 2023.
Best Growth Stocks to Buy for June 6th
by Zacks Equity Research
CCU, CLX and PHM made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 6, 2023.
Is Clorox (CLX) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Here is how Clorox (CLX) and e.l.f. Beauty (ELF) have performed compared to their sector so far this year.
Clorox (CLX) Down 9.9% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Clorox (CLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.